DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Krobot KJ, Miller WC, Kaufman JS, Christensen DB, Preisser JS, Ibrahim MA.
Quantifying delay in access to new medical treatment. An application of risk advancement period methodology.
Epidemiology 2004; 15: 202-207
We do not assume any responsibility for the contents of the web pages of other providers.